Loading...

Analysts Boost Northrop Grumman Price Target Amid Defense Growth and Mixed Sector Outlook

Published
18 Jul 24
Updated
18 Dec 25
Views
498
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
21.7%
7D
-1.3%

Author's Valuation

US$662.6814.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 18 Dec 25

Fair value Decreased 0.68%

NOC: Future Defense Budgets Will Drive Durable Cash Flows And Share Outperformance

Analysts have nudged their consolidated price target for Northrop Grumman modestly higher to reflect stable mid single digit organic growth, improving long term cash flow visibility from programs like B 21 and Sentinel, and increased budget support across key defense platforms, while fair value edged slightly lower from approximately $667 to $663 per share as a lower discount rate and marginally stronger profit margin outlook were largely offset by a slightly reduced future P E multiple.

Analyst Commentary

Bullish analysts highlight that Northrop Grumman's outlook remains steady, with guidance pointing to mid single digit organic growth through 2026 and visibility into long duration defense programs that underpin both revenue and margin durability.

Recent target price increases and an upgrade to a Buy rating suggest growing conviction that the market is underappreciating the cash flow inflection expected later in the decade as key programs scale and move into more profitable phases.

Bullish Takeaways

  • Multiple firms have raised price targets into the mid to high $600s, and one major bank now sees upside toward $700 per share, reflecting greater confidence in long term free cash flow and earnings growth.
  • Analysts view Northrop as a primary beneficiary of the 2026 defense budget proposal, citing significantly higher funding for Sentinel and B 21, alongside incremental support for TACAMO and E 2D, which strengthens the multiyear growth runway.
  • Exposure to nuclear deterrence, munitions, missiles, and space is seen as tightly aligned with Department of Defense strategic priorities, which supports premium valuation relative to more cyclically exposed peers.
  • Bullish analysts point to a post 2028 cash flow inflection as B 21 turns cash profitable and Sentinel nears full production, arguing this should support multiple resilience even as new competitors emerge.

Bearish Takeaways

  • Some cautious analysts maintain neutral or market perform stances, suggesting that much of the near term growth from key programs and budget tailwinds is already embedded in current valuation.
  • There is concern that government shutdown dynamics and broader fiscal negotiations could inject uncertainty into Q4 and FY 2026 visibility, limiting near term multiple expansion despite solid fundamentals.
  • Defense demand is described as more nuanced than commercial aerospace, with potential timing and execution risks around large programs that could pressure margins if schedules slip or costs rise.
  • While strategic positioning is strong, bearish analysts argue that the premium valuation leaves less room for error on execution of major programs and on sustaining mid single digit organic growth beyond current guidance.

What's in the News

  • The Pentagon is expected to select the builder of the Navy's next generation F A XX stealth fighter as soon as this week, with Northrop Grumman competing against Boeing for the high profile program (Reuters).
  • U S defense officials are pressing major missile manufacturers, including Northrop Grumman, to double or even quadruple production capacity to prepare for potential conflict scenarios with China (Wall Street Journal).
  • Defense Secretary Pete Hegseth has called an urgent, in person gathering of top U S military commanders, underscoring an elevated focus on strategic readiness that could reinforce demand for defense contractors such as Northrop Grumman (Washington Post).

Valuation Changes

  • Fair Value: edged down slightly from approximately $667.21 to $662.68 per share, reflecting a modest recalibration of long term assumptions.
  • Discount Rate: decreased slightly from about 8.20 percent to 7.97 percent, implying a marginally lower perceived risk profile or cost of capital.
  • Revenue Growth: remained effectively unchanged, easing only fractionally from roughly 5.43 percent to 5.42 percent, indicating a stable top line outlook.
  • Net Profit Margin: improved slightly from about 9.39 percent to 9.40 percent, signaling a marginally more favorable profitability expectation.
  • Future P/E: declined modestly from around 25.51x to 25.17x, suggesting a slightly lower anticipated valuation multiple on forward earnings.

Key Takeaways

  • Elevated defense spending, robust international demand, and leadership in next-generation platforms are strengthening revenue growth and enhancing operating margins.
  • Expansion in high-growth market segments and supportive government actions are improving program execution, cash flow, and long-term earnings stability.
  • Heavy dependence on major defense contracts, shifting global priorities, and execution risks threaten sustained growth, margin stability, and future international positioning.

Catalysts

About Northrop Grumman
    Operates as an aerospace and defense technology company in the United States, the Asia/Pacific, Europe, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Accelerating U.S. and allied defense spending, supported by substantial increases in procurement and RDT&E budgets (e.g., 22% increase in U.S. spending for FY26) and significant new funding for key Northrop Grumman programs (B-21, Sentinel, and E-2D), is expected to drive sustained revenue growth and provide multi-year order visibility.
  • Global proliferation of advanced military threats and the strategic importance of missile defense and space-based systems are leading to robust international demand, with 18% year-over-year international sales growth and strong awards in markets such as Europe and the Middle East, which should further support both revenue expansion and higher-margin contracts.
  • Northrop Grumman's leadership on next-generation platforms, including the B-21 Raider and Sentinel programs, is benefiting from both improved program execution and favorable customer incentives, positioning these programs to contribute meaningfully to operating margins and earnings over the coming years as production ramps occur.
  • The ramp-up of advanced autonomous and integrated systems such as Beacon and IBCS, combined with ongoing investments in solid rocket motor capacity (targeting a near-doubling by 2029), positions the company to capitalize on high-growth, higher-margin market segments, thereby enhancing future operating margins and underlying cash flow.
  • Supportive government actions to remove regulatory and contractual barriers are leading to faster program execution and improved incentives, which, coupled with targeted capital investments and a strong backlog, are expected to improve earnings stability, free cash flow, and long-term profitability.

Northrop Grumman Earnings and Revenue Growth

Northrop Grumman Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Northrop Grumman's revenue will grow by 5.5% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 9.7% today to 9.3% in 3 years time.
  • Analysts expect earnings to reach $4.4 billion (and earnings per share of $32.65) by about September 2028, up from $3.9 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 23.2x on those 2028 earnings, up from 20.7x today. This future PE is lower than the current PE for the US Aerospace & Defense industry at 34.4x.
  • Analysts expect the number of shares outstanding to decline by 1.72% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.11%, as per the Simply Wall St company report.

Northrop Grumman Future Earnings Per Share Growth

Northrop Grumman Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • While current demand and backlog are strong, long-term reliance on sizable U.S. government contracts (particularly B-21 and Sentinel) exposes Northrop Grumman to significant programmatic and budgetary risks including potential delays, cancellations, or changes in political priorities that could reduce revenue visibility and create volatility in top-line growth.
  • Growing partnerships with international allies are driving up overseas sales, but the trend toward European and other allied nations developing indigenous defense capabilities could erode Northrop Grumman's long-term international market share, eventually impacting revenue and limiting margin upside.
  • The company's strategy increasingly relies on large, high-cost hardware systems, even as global defense budgets may gradually shift toward software, cyber, and attritable/autonomous platforms; if Northrop is outpaced by more agile competitors in these emerging domains, it could face slower growth and potential margin compression.
  • Heavy ongoing capital investments in facilities, production capacity, and innovation expose the company to execution risks and create the potential for cost overruns, which-given fixed-price contract structures-could squeeze net margins and earnings if not perfectly managed or if awards/contracts do not materialize as expected.
  • Persistent regulatory and political attention on defense spending, combined with changing tax treatment (e.g., R&D credits), ESG pressures, and the risk of future arms control or budget constraints, could dampen institutional investor interest, reduce valuation multiples, and put long-term pressure on earnings and cash flow.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $603.316 for Northrop Grumman based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $690.0, and the most bearish reporting a price target of just $510.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $47.5 billion, earnings will come to $4.4 billion, and it would be trading on a PE ratio of 23.2x, assuming you use a discount rate of 8.1%.
  • Given the current share price of $571.63, the analyst price target of $603.32 is 5.3% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Northrop Grumman?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives